Stock listing
ASX:AN1 Anagenics Limited Share Price
Follow Anagenics Limited into a list and get an email when it puts out news.
Share price · ASX:AN1
$0.0060 AUD 0.0000 (0.0%)
Close on Nov 19, 2026
- Day range
- $0.0060 – $0.0060 AUDNov 19, 2026
- Market cap
- $5.91M AUDAt the close on Nov 19, 2026 · price × 985.5M shares outstanding
- 52-week range
- $0.0040 – $0.0090 AUDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $1,209 AUDMedian day 0 shares · 34 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026

Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · ASX:AN1 · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | -0.0010 | -14.3% | $0.0070 | $0.0070 | $0.0060 | 891,746 | |
| $0.0070 | 0.0000 | 0.0% | $0.0070 | $0.0070 | $0.0070 | 0 | |
| $0.0070 | 0.0000 | 0.0% | $0.0070 | $0.0070 | $0.0070 | 0 | |
| $0.0070 | +0.0010 | +16.7% | $0.0070 | $0.0070 | $0.0070 | 308,586 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 1,217,504 | |
| $0.0060 | +0.0010 | +20.0% | $0.0050 | $0.0060 | $0.0050 | 329,738 | |
| $0.0050 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0050 | 4,425,887 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 484,377 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0040 | 66,118 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 5,000 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 10,000 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 26,000 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 1,563 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 2,000,000 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 190,675 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 250,000 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 344,673 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 919,384 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 500,000 | |
| $0.0050 | -0.0010 | -16.7% | $0.0050 | $0.0050 | $0.0050 | 500,000 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 328 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0050 | $0.0060 | $0.0050 | 152,198 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 10,302 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 375,160 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0050 | 289,066 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 2,000 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 120,000 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 170,833 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 470,667 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 6,333 | |
| $0.0060 | 0.0000 | 0.0% | $0.0070 | $0.0070 | $0.0060 | 737,000 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 99,550 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 149,167 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0050 | 14,350 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 2,663 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0060 | 0 |
Splits
2 splits since 2017 · ASX:AN1 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 101-for-94 | Split | |
| 1-for-20 | Consolidation |
- Ticker
- ASX:AN1
- Asset type
- Stock
- Sector
- Consumer goods
- Industry
- Household & personal care
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Nov 20, 2026
AGM Update
Latest deck · Feb 25, 2026
H1 2026 Earnings Presentation
Earnings · 12 slides
Latest news
Application for quotation of securities - AN1
Nov 15, 2026
Closed $0.0060 (-14.3%) on Nov 16, 2026
Proposed issue of securities - AN1
Nov 11, 2026
Closed $0.0070 (0.0%) on Nov 12, 2026
Anagenics to Acquire Bio-First Skincare Brand
Nov 10, 2026
Closed $0.0070 (+16.7%) on Nov 11, 2026
Sale of Intellectual Property and Earn-Out Arrangement
Nov 4, 2026
Closed $0.0050 (0.0%) on Nov 5, 2026
Pause in Trading
Nov 4, 2026
Closed $0.0050 (0.0%) on Nov 5, 2026
AN1 - Appendix 4C & Activity Report for Q1 FY2027
Oct 22, 2026
Closed $0.0050 (0.0%) on Oct 23, 2026
Notice of Annual General Meeting/Proxy Form
Oct 5, 2026
Closed $0.0060 (0.0%) on Oct 5, 2026
AN1 FY26-Appendix-4E-
Aug 28, 2026
Closed $0.0060 (0.0%) on Aug 31, 2026
Anagenics Limited on 6ix
- Sector
- Consumer goods
- Industry
- Household & personal care
- News releases
- 20 in the last 12 months · 177 in all · newest Nov 20, 2026 · oldest 2016
- Decks
- 38 decks · latest Feb 25, 2026
Valuation
P/E 19.2× against a median of 13.4×: the highest of 3 Household & personal care companies shown. Statements: Year to Jun 30, 2026 · price Nov 19, 2026
- Enterprise value
- $5.37M AUD
- P/E
- 19.2×
- EV/sales
- 1.0×
- EV/EBITDA
- 6.6×
- Price/book
- 1.4×
- Gross margin
- 54.5%
- Operating margin
- 12.2%
- Net margin
- 6.0%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Household & personal care: the 10 companies nearest in size, of 134 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Anagenics Limited · ASX:AN1 | US$3.91M | US$3.55M | 19.2× | 1.0× | 6.6× | 1.4× | 6.0% | 0.0× | n/a |
| JHS Svendgaard Laboratories Limited · NSE:JHS | US$7.48M | US$8.49M | n/a | 0.7× | 29.9× | 0.4× | −1.1% | 0.1× | n/a |
| La Savonnerie de Nyons SA · EURONEXT:MLSDN | US$7.28M | US$6.24M | 11.2× | 1.3× | 6.6× | 1.9× | 13.5% | 0.2× | n/a |
| Miraculum S.A. · GPW:MIR | US$6.97M | US$10.23M | n/a | 0.8× | 40.6× | 1.0× | −2.0% | 0.5× | n/a |
| Caring Brands, Inc. · NASDAQ:CABR | US$6.91M | −US$759,746 | n/a | n/a | n/a | 0.9× | n/a | 0.0× | 0.78 |
| Eng Kah Corp. Bhd. · MYX:ENGKAH | US$5.41M | US$1.72M | n/a | 0.2× | n/a | 0.5× | −28.1% | 0.0× | n/a |
| Sea Mild Biotechnology Co., Ltd. · TPEX:7516 | US$4.16M | US$2.23M | 15.5× | 0.2× | 2.4× | 1.2× | 2.6% | 0.1× | n/a |
| CCA Industries, Inc. · OTC:CAWW | US$2.64M | US$2.93M | n/a | 0.6× | n/a | 0.8× | −6.8% | 0.1× | 0.08 |
| Dermata Therapeutics, Inc. · NASDAQ:DRMA | US$2.52M | −US$2.30M | n/a | −31.0× | n/a | 0.7× | n/a | 0.0× | 1.22 |
| Skin Laboratory Public Company Limited · SET:SKIN | US$2.50M | US$827,978 | n/a | 0.2× | n/a | 1.0× | −12.0% | 0.0× | n/a |
| Highlander Enterprise S.A. · NEWCONNECT:HER | US$2.14M | US$2.14M | n/a | 16.0× | 8.7× | 54.7× | −194.8% | 0.0× | n/a |
| Median of the others | US$4.78M | US$2.19M | 13.4× | 0.6× | 8.7× | 0.9× | −4.4% | 0.0× | 0.78 |
Team and board
Officers
| Officer | Role |
|---|---|
| Scott Greasley | Executive Director |
Board
| Director | Role |
|---|---|
| Sandy Beard | Chairman |
| Phillip Christopher | Non-Executive Director |
| Scott Greasley | Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Aug 27, 2025 | −16.7% |
| Q2 2025 | Feb 27, 2025 | 0.0% |
| Q2 2023 | Feb 13, 2023 · After close | |
| Q4 2022 | Aug 24, 2022 · After close | 0.0% |
| Q2 2022 | Feb 15, 2022 | +4.0% |
| Q4 2021 | Aug 25, 2021 | 0.0% |
| Quarter to Dec 31, 2020 | Feb 17, 2021 | −7.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026 Earnings Presentation | Earnings | 12 slides | Feb 25, 2026 |
| Shareholder Meeting (November 2025) | Shareholder meeting | 14 slides | Nov 25, 2025 |
| FY2025 Earnings Presentation | Earnings | 15 slides | Aug 28, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 15 slides | May 5, 2025 |
| Shareholder Meeting (November 2024) | Shareholder meeting | 12 slides | Nov 26, 2024 |
| FY2024 Earnings Presentation | Earnings | 14 slides | September 2024 |
| Investor Presentation (February 2024) | Investor deck | 16 slides | Feb 7, 2024 |
| Shareholder Meeting (November 2023) | Shareholder meeting | 10 slides | Nov 1, 2023 |
| Merger or Acquisition (August 2023) | Merger or acquisition | 12 slides | Aug 22, 2023 |
| Investor Presentation (February 2023) | Investor deck | 27 slides | Feb 14, 2023 |
All 38 decks
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of securities Announced: private placement | Nov 12, 2026 | |
| Private placement of new shares Announced: A$2.25M · A$0.0046 a share Use of proceeds: Expand existing brands, pursue complementary business opportunities, retire debt, working capital and placement costs | Dec 10, 2025 | US$1.5M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.16M | 4.75M | 10.8M | 9.11M | 6.95M | 5.82M | 7.38M | 7.30M | 5.65M | 4.50M |
| Cost of revenue | 2.35M | 2.71M | 6.44M | 5.06M | 3.15M | 2.11M | 2.53M | 2.14M | 5.62M | 4.83M |
| Gross profit | 2.81M | 2.04M | 4.36M | 4.05M | 3.80M | 3.70M | 4.85M | 5.16M | 27.9K | -331.4K |
| Research and development | 8.68K | 21.2K | 26.2K | 118.8K | 849.0K | 848.5K | 598.5K | 599.6K | ||
| Selling, general and administrative | 2.02M | 2.50M | 7.87M | 4.12M | 118.9K | 64.8K | 5.18M | 5.38M | 3.67M | 2.78M |
| Operating income | 629.8K | -1.32M | -7.38M | -1.92M | -1.60M | -3.64M | -4.75M | -5.65M | -3.26M | -4.14M |
| Depreciation and amortization | 186.2K | 200.4K | 616.3K | 359.8K | 495.5K | 434.6K | 518.7K | 152.9K | 187.5K | 168.5K |
| EBITDA | 816.1K | -1.12M | -6.76M | -1.56M | -1.10M | -3.21M | -4.23M | -5.50M | -3.07M | -3.97M |
| Interest expense | 69.2K | 40.5K | 66.3K | 31.8K | 25.0K | 54.8K | 71.3K | 235.0K | 473.3K | 291.2K |
| Income before tax | 308.5K | -1.24M | -7.28M | -2.20M | -1.64M | -3.76M | -4.82M | -5.89M | -3.73M | -4.43M |
| Income tax | 209.0K | -454.7K | 152 | 45.0K | 89.5K | 24.1K | 2.43K | 35.6K | ||
| Net income | 308.5K | -1.24M | -7.49M | -2.67M | -3.65M | -3.39M | -4.91M | -5.91M | -3.73M | -4.47M |
| Earnings per share, basic | 0.00 | -0.00 | -0.02 | -0.01 | -0.02 | -0.02 | -0.05 | -0.07 | -0.06 | -0.08 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 577.4K | 395.5K | 1.62M | 2.57M | 3.28M | 6.73M | 6.97M | 3.08M | 1.61M | 3.99M |
| Receivables | 805.4K | 574.8K | 651.5K | 1.09M | 921.3K | 1.80M | 1.87M | 2.29M | 1.03M | 378.3K |
| Inventory | 1.03M | 967.7K | 1.48M | 2.40M | 4.45M | 2.55M | 2.61M | 1.62M | 1.18M | 2.08M |
| Current assets | 2.74M | 1.94M | 3.83M | 6.25M | 8.77M | 11.3M | 11.6M | 7.23M | 4.16M | 6.56M |
| Property, plant and equipment | 211.2K | 411.6K | 772.8K | 578.3K | 527.3K | 1.50M | 800.2K | 771.0K | 744.7K | |
| Goodwill | 1.95M | 1.95M | 1.95M | 3.45M | 3.45M | |||||
| Total assets | 4.75M | 4.10M | 6.19M | 11.1M | 12.9M | 13.3M | 14.9M | 9.79M | 6.75M | 8.47M |
| Accounts payable | 315.9K | 1.06M | 1.69M | 724.1K | 502.7K | 682.2K | 839.7K | 685.2K | 603.8K | 680.8K |
| Current liabilities | 520.8K | 2.19M | 3.17M | 1.71M | 3.66M | 1.92M | 3.48M | 2.91M | 3.72M | 3.76M |
| Long-term debt | 0 | 767.5K | 601.4K | 1.03M | 1.02M | 1.17M | 314.6K | |||
| Total debt | 33.2K | 848.1K | 772.6K | 654.3K | 1.76M | 1.43M | 1.96M | 1.29M | 3.17M | 2.16M |
| Total liabilities | 520.8K | 2.28M | 3.48M | 2.22M | 4.64M | 2.86M | 5.08M | 3.93M | 4.89M | 4.08M |
| Shareholders' equity | 4.23M | 1.83M | 2.71M | 8.90M | 8.29M | 10.4M | 9.81M | 5.86M | 1.86M | 4.40M |
| Shares outstanding | 743.0M | 469.4M | 399.0M | 266.0M | 211.4M | 142.5M | 105.6M | 82.1M | 60.1M | 55.3M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.07M | -1.58M | -1.74M | -1.78M | -2.53M | -4.11M | -4.01M | -5.93M | -4.40M | -4.06M |
| Capital spending | -25.0K | -3 | -97.9K | -45.4K | -35.9K | -22.5K | -22.5K | -65.7K | -107.2K | -35.9K |
| Free cash flow | -1.09M | -1.58M | -1.84M | -1.83M | -2.59M | -22.5K | -4.01M | -6.00M | -4.51M | -4.10M |
| Cash from investing | -25.0K | 0 | -197.9K | -1.51M | -968.2K | 477.5K | 477.5K | -65.7K | -214.1K | -35.9K |
| Cash from financing | 1.28M | 345.4K | 993.7K | 2.56M | 73.3K | 3.50M | 7.98M | 7.27M | 2.19M | 5.44M |
| Dividends paid | -271.4K | -54.8K | -202.2K | |||||||
| Share buybacks | -150.9K | 0 | -149.3K | -271.4K | 0 | -379.0K | -535.8K | -114.8K | -27.0K | 4.07M |
| Change in cash | 181.9K | -1.23M | -943.1K | -717.8K | -3.44M | -243.2K | 3.89M | 1.47M | -2.39M | 1.31M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| AGM Update | Nov 19, 2026 | Meeting notice | ASX |
| Notices under sections 203D and 249D of the Corporations Act | Nov 19, 2026 | Other filings | ASX |
| Application for quotation of securities - AN1 | Nov 15, 2026 | Financing | ASX |
| Proposed issue of securities - AN1 | Nov 11, 2026 | Financing | ASX |
| Anagenics to Acquire Bio-First Skincare Brand | Nov 10, 2026 | Acquisition or disposal | ASX |
| Sale of Intellectual Property and Earn-Out Arrangement | Nov 4, 2026 | Acquisition or disposal | ASX |
| Pause in Trading | Nov 4, 2026 | Trading halt or suspension | ASX |
| AN1 - Appendix 4C & Activity Report for Q1 FY2027 | Oct 22, 2026 | Quarterly report | ASX |
| Notice of Annual General Meeting/Proxy Form | Oct 5, 2026 | Meeting notice | ASX |
| AN1 FY26-Appendix-4E- | Aug 28, 2026 | Results | ASX |
All 170 filings
Cap table
Built by 6ix from Anagenics Limited’s releases · as of Nov 12, 2026
- Common shares
- 985,450,795
- Fully diluted
- 985,450,795
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 985,450,795 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 985,450,795 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Phillip Christopher | Non-Executive Director · Since at least Nov 5, 2026 |
| Sandy Beard | Chairman · Since at least Nov 4, 2026 |
| Scott Greasley | Executive Director · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Anagenics Limited.